- Investing Ideas
- /
- Biotech Breakthroughs
Biotech Breakthroughs
UPDATED Apr 12, 2024
Companys with strong funding and high growth potential
26 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
0A8R | US$228.95 | 4.6% | 81.1% | US$43.2b | US$229.12 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
0ABW | kr6.85 | -3.5% | -11.5% | kr1.8b | kr14.32 | PS31.9x | E85.4% | n/a | Pharmaceuticals & Biotech | ||
0H22 | kr18.65 | 1.1% | -37.8% | kr1.2b | kr84.96 | PS16.8x | E60.1% | n/a | Pharmaceuticals & Biotech | ||
0A8K | US$31.24 | 6.4% | 658.3% | US$8.4b | US$29.16 | PS29.1x | E45.9% | n/a | Pharmaceuticals & Biotech | ||
0EVI | €2.31 | 4.4% | -23.6% | €188.8m | €6.20 | PS3.1x | E30.0% | n/a | Pharmaceuticals & Biotech | ||
0L35 | US$122.59 | -3.7% | 0.08% | US$11.7b | US$164.21 | PS9.3x | E42.3% | n/a | Pharmaceuticals & Biotech | ||
0JDK | US$12.57 | -8.6% | 123.4% | US$3.7b | US$26.43 | PS2903.5x | E61.7% | n/a | Pharmaceuticals & Biotech | ||
0A4W | US$17.12 | -5.5% | -4.0% | US$2.9b | US$29.34 | PS3.9x | E40.9% | n/a | Pharmaceuticals & Biotech | ||
LLA | UK£0.30 | 0% | n/a | UK£9.7m | UK£2.10 | PS261.3x | E88.7% | n/a | Pharmaceuticals & Biotech | ||
0IV3 | US$3.85 | 15.2% | 95.0% | US$2.2b | US$5.38 | PS9044.3x | E62.1% | n/a | Pharmaceuticals & Biotech | ||
0W4N | €47.11 | 2.4% | -29.3% | €820.3m | €97.61 | PS12x | E44.4% | n/a | Pharmaceuticals & Biotech | ||
ARGXB | €351.70 | -3.4% | 2.0% | €20.9b | €438.38 | PS17.6x | E56.3% | n/a | Pharmaceuticals & Biotech | ||
0H7R | US$7.77 | 1.1% | 164.4% | US$213.1m | US$21.62 | PS59x | E60.7% | n/a | Pharmaceuticals & Biotech | ||
0QW0 | €353.72 | -1.1% | 1.7% | €20.9b | €440.90 | PS17.6x | E56.3% | n/a | Pharmaceuticals & Biotech | ||
BINVS | kr34.75 | 0% | n/a | kr2.1b | kr124.66 | PS6.7x | E64.4% | n/a | Pharmaceuticals & Biotech | ||
XSPRAS | kr50.85 | 0% | n/a | kr1.1b | kr153.70 | PB1.7x | E221.0% | n/a | Pharmaceuticals & Biotech | ||
FYBD | €63.30 | 0% | -11.1% | €911.0m | €118.80 | PS13.3x | E80.8% | n/a | Pharmaceuticals & Biotech | ||
0JXI | US$241.83 | -1.0% | 1.1% | US$5.1b | US$403.28 | PB12.3x | E62.2% | n/a | Pharmaceuticals & Biotech | ||
LLAI | UK£0.32 | 6.8% | -59.4% | UK£9.7m | UK£2.20 | PS261.3x | E88.7% | n/a | Pharmaceuticals & Biotech | ||
0QT6 | €3.32 | 3.7% | -6.1% | €165.0m | €9.38 | PS4.8x | E54.7% | n/a | Pharmaceuticals & Biotech | ||
0HOJ | US$90.32 | -1.0% | n/a | US$5.6b | US$100.80 | PS21.4x | E66.2% | n/a | Pharmaceuticals & Biotech | ||
0QCO | €1.01 | 1.2% | -1.3% | €680.2m | €2.01 | PS2.9x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
DBVP | €3.61 | 0% | n/a | €284.7m | €7.52 | PS59.3x | E42.1% | n/a | Pharmaceuticals & Biotech | ||
0QAJ | €1.27 | -8.2% | -60.1% | €120.8m | €4.84 | PS8.2x | E53.3% | n/a | Pharmaceuticals & Biotech |